A protein may help brain tumors hide from the immune system
Original title: Cross-species spatial profiling links progranulin to an immune suppressive niche in brain metastasis
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was done in mice and in lab dishes, not in patients.
The short version
In mice, losing a protein called progranulin left less tumor in the brain.
What was studied. Scientists studied tumors that spread to the brain from other parts of the body. They looked at five mouse models, immune cells in dishes, and human tumor samples.
What they found. The tumors were packed with immune cells of a certain type. A protein called progranulin seemed to help those cells hold back the immune attack. When mice lost this protein, there was less tumor in the brain. In human samples, high levels of the protein sat next to worn out immune cells.
What this means, and what it doesn't
What it could mean: This points to a possible new target for future drugs. It may help explain why about 50% of patients do not respond to drugs that wake up the immune system. Nothing about care today changes because of this.
What it doesn't mean: This does not mean there is a new treatment. The work was done in mice, in lab dishes, and in stored human samples. No drug for this protein has been tested in people. It is not a cure, and it is far from everyday care.
Source: bioRxiv (preprint), September 19, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.